New Model of Care in Heart Failure

NACompletedINTERVENTIONAL
Enrollment

605

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

October 31, 2020

Study Completion Date

March 30, 2021

Conditions
Heart Failure
Interventions
PROCEDURE

new model of ambulatory care with use of of non-invasive vital signs assessment and telemedicine

"The report of symptoms and physical examination will be obligatory performed by the ACP nurse. Self-condition and quality of life assessment at every visit will be based on EQ-5D questionnaire and VAS 10-points scale Hemodynamic assessment - the ACP nurse will perform impedance cardiography (cardiomonitor) and bioimpedance (scale). The parameters measured by ICG and bioimpedance will be assessed with respect to individually defined target values for: heart rate (HR), systolic and diastolic blood pressure (SBP and DBP), thoracic fluid content (TFC) and its change (delta TFC), change of body mass and total body water (delta TBW).~Supervising physician will confront ICG/bioimpedance results with the patient's clinical data and give final remote recommendations."

Trial Locations (1)

04-141

Military Institute of Medicine, Warsaw

All Listed Sponsors
collaborator

Wroclaw Medical University

OTHER

collaborator

4th Military Clinical Hospital with Polyclinic, Poland

OTHER

collaborator

Medical University of Gdansk

OTHER

collaborator

Military University of Technology

UNKNOWN

lead

Military Institute od Medicine National Research Institute

OTHER

NCT03476590 - New Model of Care in Heart Failure | Biotech Hunter | Biotech Hunter